14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
NDAQ vs CME: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Nasdaq, Inc. (NDAQ) captures the overall head-to-head institutional edge over CME Group Inc. (CME) on higher Unified Composite conviction (45.2/100 HOLD vs. 38.6/100 SELL) after splitting the core matrix 3–7 (led by Valuation Multiples, R&D & Supply-Chain Moat), while CME wins 4–2 across the 6-pillar growth and valuation breakdown. NDAQ trades at $105.32 (22.9x Forward P/E, 49.0% operating margin) versus CME at $311.77 (24.1x Forward P/E, 66.2% operating margin).
Growth vs. Quality Trade-Off: NDAQ earns the overall head-to-head edge with a stronger Unified Composite Score (45.2/100 HOLD vs. CME 38.6/100 SELL) and 0.43β · 32% Vol risk profile, whereas CME leads top-line expansion (+13.0% YoY revenue growth, 4.38x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Competes within the Financial Data & Stock Exchanges value chain with $60.2B market capitalization and 49.0% operating margin.
OpEx & R&D Reinvestment51.0% of Rev ($2.95B)
90D Engineering Disclosures0 Published
CME Moat ProfileHigh-Margin Pricing Power Moat
Financial Data & Stock Exchanges Operator
Competes within the Financial Data & Stock Exchanges value chain with $113.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment33.8% of Rev ($2.35B)
90D Engineering Disclosures0 Published
Investor FAQ NDAQ vs CME Key Questions & Quantitative Answers
As of Nov 17, 2026, Nasdaq, Inc. (NDAQ) captures the overall head-to-head institutional edge over CME Group Inc. (CME) on higher Unified Composite conviction (45.2/100 HOLD vs. 38.6/100 SELL) after splitting the core matrix 3–7 (led by Valuation Multiples, R&D & Supply-Chain Moat), while CME wins 4–2 across the 6-pillar growth and valuation breakdown. NDAQ trades at $105.32 (22.9x Forward P/E, 49.0% operating margin) versus CME at $311.77 (24.1x Forward P/E, 66.2% operating margin). Growth vs. Quality Trade-Off: NDAQ earns the overall head-to-head edge with a stronger Unified Composite Score (45.2/100 HOLD vs. CME 38.6/100 SELL) and 0.43β · 32% Vol risk profile, whereas CME leads top-line expansion (+13.0% YoY revenue growth, 4.38x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
CME leads the Growth & Scale pillar: NDAQ posts +12.6% YoY revenue growth and +31.5% YoY earnings growth on $5.78B TTM revenue (100.0% gross margin, 49.0% operating margin), compared with CME at +13.0% YoY revenue growth and +16.1% YoY earnings growth on $6.96B TTM revenue (100.0% gross margin, 66.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), NDAQ cumulative revenue shifted +93.0% while CME shifted +51.3%. In operating R&D and SG&A reinvestment, NDAQ deploys 51.0% of Rev ($2.95B) (0 90-day corporate R&D disclosures) versus 33.8% of Rev ($2.35B) (0 disclosures) for CME.
NDAQ screens cheaper on headline valuation multiples. NDAQ trades at 22.9x Forward P/E, 29.6x Trailing P/E, 1.68x PEG, and 11.9x EV/Revenue (39.1% FCF margin), whereas CME trades at 24.1x Forward P/E, 26.1x Trailing P/E, 4.38x PEG, and 16.5x EV/Revenue (62.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NDAQ (17.3% ROE) versus CME (16.1% ROE) capital efficiency.
In options market volatility and institutional positioning, NDAQ carries 35.8% implied volatility (10th %ile, Compressed (<25th %ile)), a 0.57x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.43β · 32% Vol realized risk). By comparison, CME carries 24.0% implied volatility (10th %ile, Compressed (<25th %ile)), a 0.40x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.32β · 26% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.